ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...
How KFSHRC's Advanced Hematology Laboratory Is Transforming Diagnostics Across The Middle East. EINPresswire / -- At King Faisal Specialist Hospital and Research Centre (KFSHRC), hematology ...
As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...
The human body relies on precise genetic instructions to function, and cancer begins when these instructions get scrambled.
A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...
News Medical on MSN
Rapamycin shows promise in treating cold tumors with specific gene mutation
Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have ...
The Labaid Group is developing AI-based healthtech solutions and plans to establish 30 satellite cancer centres across Bangladesh to usher in a more precise healthcare. In an interview with The ...
Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others. Their discovery opens the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results